Growth and Tolerance of Infants Fed Milk-Based Infant Formula

Gastro-Intestinal Tolerance Clinical Trial

Official title:
Growth and Tolerance of Young Infants Fed Milk-Based Infant Formula With Oligosaccharides

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate growth and tolerance of healthy term infants fed an experimental milk-based infant formula with oligosaccharides compared to a control milk-based infant formula.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Gastro-Intestinal Tolerance

Clinical Trial Details

NCT number	NCT03967132
Study type	Interventional
Source	Abbott Nutrition
Contact
Status	Completed
Phase	N/A
Start date	June 8, 2019
Completion date	May 29, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03293706` - Evaluation of Carbohydrates Part 2	N/A
Completed	`NCT01781624` - Evaluation of an Oral Nutritional Supplement	N/A
Completed	`NCT01782456` - Tolerance of an Oral Nutritional Supplement(ONS)	N/A
Completed	`NCT04259437` - Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition	N/A
Terminated	`NCT04934397` - Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula	N/A
Completed	`NCT04915937` - Formula Tolerance of Term Infants	N/A
Withdrawn	`NCT04104815` - GI Tolerance and Acceptability of a New Thickener	N/A